Von Willebrand Diseases Clinical Trials

10 recruitingLast updated: May 21, 2026

There are 10 actively recruiting von willebrand diseases clinical trials across 9 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3. Top locations include Atlanta, Georgia, United States, Seattle, Washington, United States, Aurora, Colorado, United States. Updated daily from ClinicalTrials.gov.


Von Willebrand Diseases Trials at a Glance

10 actively recruiting trials for von willebrand diseases are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Atlanta, Seattle, and Aurora. Lead sponsors running von willebrand diseases studies include American Thrombosis and Hemostasis Network, Oregon Health and Science University, and Centre Hospitalier Universitaire Dijon.

Browse von willebrand diseases trials by phase

About Von Willebrand Diseases Clinical Trials

Looking for clinical trials for Von Willebrand Diseases? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Von Willebrand Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Von Willebrand Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

ATHNdataset Registry

ThrombosisSickle Cell DiseaseHemophilia A+6 more
American Thrombosis and Hemostasis Network200,000 enrolled1 locationNCT06820515
Recruiting

Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions

Von Willebrand DiseasesMajor Constitutional ThrombopathyPatient on Antiplatelet Drugs
Centre Hospitalier Universitaire Dijon200 enrolled2 locationsNCT03773159
Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

ThrombophiliaThrombosisSickle Cell Disease+10 more
American Thrombosis and Hemostasis Network3,000 enrolled71 locationsNCT04398628
Recruiting

Von Willebrand Factor in Pregnancy (VIP) Study

Von Willebrand Diseases
University of Washington110 enrolled11 locationsNCT04146376
Recruiting

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

Bleeding DisorderHeavy Menstrual BleedingVon Willebrand Diseases
Oregon Health and Science University300 enrolled9 locationsNCT05916469
Recruiting
Phase 1Phase 2

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

Von Willebrand Diseases
Vega Therapeutics, Inc116 enrolled25 locationsNCT05776069
Recruiting

Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West

Von Willebrand Diseases
University Hospital, Brest100 enrolled6 locationsNCT05773638
Recruiting
Phase 3

A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD

Von Willebrand Diseases
Unity Health Toronto20 enrolled1 locationNCT06205095
Recruiting
Not Applicable

Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases

Von Willebrand DiseasesGlanzmann Thrombasthenia
University Hospital, Lille400 enrolled1 locationNCT04119908
Recruiting

World Bleeding Disorders Registry

Hemophilia AHemophilia BVon Willebrand Diseases
World Federation of Hemophilia20,000 enrolled1 locationNCT03327779